AU2001281967A1 - Regulation of human desc1-like serine protease - Google Patents
Regulation of human desc1-like serine proteaseInfo
- Publication number
- AU2001281967A1 AU2001281967A1 AU2001281967A AU8196701A AU2001281967A1 AU 2001281967 A1 AU2001281967 A1 AU 2001281967A1 AU 2001281967 A AU2001281967 A AU 2001281967A AU 8196701 A AU8196701 A AU 8196701A AU 2001281967 A1 AU2001281967 A1 AU 2001281967A1
- Authority
- AU
- Australia
- Prior art keywords
- regulation
- serine protease
- desc1
- human
- human desc1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000012479 Serine Proteases Human genes 0.000 title 1
- 108010022999 Serine Proteases Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Psychology (AREA)
- Pulmonology (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21883200P | 2000-07-18 | 2000-07-18 | |
US60/218,832 | 2000-07-18 | ||
PCT/EP2001/007859 WO2002006453A2 (fr) | 2000-07-18 | 2001-07-09 | Regulation de protease a serine humaine de type desc1 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001281967A1 true AU2001281967A1 (en) | 2002-01-30 |
Family
ID=22816685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001281967A Abandoned AU2001281967A1 (en) | 2000-07-18 | 2001-07-09 | Regulation of human desc1-like serine protease |
Country Status (5)
Country | Link |
---|---|
US (1) | US20030171324A1 (fr) |
EP (1) | EP1303620A2 (fr) |
JP (1) | JP2004504026A (fr) |
AU (1) | AU2001281967A1 (fr) |
WO (1) | WO2002006453A2 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1230349B1 (fr) | 1999-11-18 | 2007-06-13 | Dendreon Corporation | Acides nucleiques codant pour des endotheliases, endotheliases et leurs utilisations |
US7700341B2 (en) | 2000-02-03 | 2010-04-20 | Dendreon Corporation | Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
US6365391B1 (en) * | 2000-09-27 | 2002-04-02 | Pe Corporation (Ny) | Isolated human serine protease, nucleic acid molecules encoding human serine protease, and uses thereof |
AU2002305052A1 (en) | 2001-03-13 | 2002-09-24 | Corvas International, Inc. | Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon |
US7172892B2 (en) | 2001-03-22 | 2007-02-06 | Dendreon Corporation | Nucleic acid molecules encoding serine protease CVSP14, the encoded polypeptides and methods based thereon |
US7105333B2 (en) * | 2001-03-27 | 2006-09-12 | Deadreon Corporation | Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon |
EP1539942A4 (fr) | 2001-05-14 | 2005-10-19 | Dendreon Corp | Molecules d'acides nucleiques codant pour une serine protease transmembranaire 10, polypeptides codes et methodes associees |
UA80543C2 (en) | 2001-12-04 | 2007-10-10 | Wyeth Corp | Method for the preparation of o-desmethylvenlafaxine |
JPWO2003062429A1 (ja) * | 2002-01-23 | 2005-05-26 | 山之内製薬株式会社 | 新規セリンプロテアーゼ |
BRPI0612268A2 (pt) * | 2005-06-21 | 2009-01-27 | Medimmune Vaccines Inc | Ácido nucleico isolado, vetor de expressço, mÉtodos para produzir um rna genâmico da influenza, para produzir um vÍrus da influenza recombinante, para gerar um vÍrus de rna segmentado de filamento negativo recombinante nas cÉlulas caninas cultivadas e para gerar partÍculas virais da influenza infecciosa em cÉlulas caninas cultivadas, cÉlula, e, vÍrus |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1068900A (en) * | 1999-02-26 | 2000-09-14 | Ohio State University Research Foundation, The | Detecting the expression of the desc1 gene in squamous cell carcinoma |
CA2391908A1 (fr) * | 1999-11-17 | 2001-05-25 | Curagen Corporation | Nouveaux polypeptides et acides nucleiques codant les memes |
WO2001055168A1 (fr) * | 2000-01-31 | 2001-08-02 | Human Genome Sciences, Inc. | Acides nucleiques, proteines, et anticorps |
WO2001055325A2 (fr) * | 2000-01-31 | 2001-08-02 | Human Genome Sciences, Inc. | Acides nucleiques, proteines et anticorps |
US6436703B1 (en) * | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
CA2412635A1 (fr) * | 2000-06-26 | 2002-01-03 | Sugen, Inc. | Nouvelles proteases |
US6365391B1 (en) * | 2000-09-27 | 2002-04-02 | Pe Corporation (Ny) | Isolated human serine protease, nucleic acid molecules encoding human serine protease, and uses thereof |
-
2001
- 2001-07-09 US US10/332,122 patent/US20030171324A1/en not_active Abandoned
- 2001-07-09 JP JP2002512346A patent/JP2004504026A/ja active Pending
- 2001-07-09 EP EP01960480A patent/EP1303620A2/fr not_active Withdrawn
- 2001-07-09 AU AU2001281967A patent/AU2001281967A1/en not_active Abandoned
- 2001-07-09 WO PCT/EP2001/007859 patent/WO2002006453A2/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2004504026A (ja) | 2004-02-12 |
EP1303620A2 (fr) | 2003-04-23 |
WO2002006453A2 (fr) | 2002-01-24 |
US20030171324A1 (en) | 2003-09-11 |
WO2002006453A3 (fr) | 2002-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002224553A1 (en) | Human proteases | |
AU2001278488A1 (en) | Regulation of human matriptase-like serine protease | |
AU2001281967A1 (en) | Regulation of human desc1-like serine protease | |
AU2001283872A1 (en) | Regulation of human eosinophil serine protease 1-like enzyme | |
AU8573401A (en) | Regulation of human epithin-like serine protease | |
AU5290499A (en) | Human htra serine protease | |
AU2001266089A1 (en) | Regulation of human prostasin-like serine protease | |
AU2001293718A1 (en) | Regulation of human membrane-type serine protease | |
AU2002234568A1 (en) | Regulation of human serine palmitoyltransferase | |
AU2001268967A1 (en) | Regulation of human epithin-like serine protease | |
AU2001269095A1 (en) | Regulation of human caspase-1-like protease | |
AU2002213949A1 (en) | Regulation of human serine protease | |
AU2001279752A1 (en) | Regulation of human masp-like serine protease | |
AU1624501A (en) | Human serine protease | |
AU2001281950A1 (en) | Regulation of human thimet oligopeptidase-like enzyme | |
AU2001256350A1 (en) | Regulation of human lysostaphin-like protease | |
AU2001274080A1 (en) | Regulation of human transketolase-like enzyme | |
AU2002212246A1 (en) | Regulation of human serine palmitoyltransferase-like enzyme | |
AU2003250830A1 (en) | Regulation of human subtilase-like serine protease | |
AU2001238721A1 (en) | Human serine protease | |
AU2002223522A1 (en) | Regulation of human pyroglutamyl peptidase-like enzyme | |
AU2001269097A1 (en) | Regulation of human epidermis-specific serine protease | |
AU2001293846A1 (en) | Regulation of a human serine protease | |
AU2001267548A1 (en) | Regulation of human napsin-like aspartyl protease | |
AU2001258330A1 (en) | New uses of imidazolylmethyl-pyridines |